Agilent and Monash Malaysia launch cutting-edge BioDiscovery hub to boost regional biotech
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
76 of 180 long COVID-associated genes also linked to ME
While Merck can appeal, Halozyme said it expects the order to hold
MRI is particularly valuable in pediatric care due to its non-invasive nature
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Growing patent filings and tier-2 innovators reflect expanding national research base
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Subscribe To Our Newsletter & Stay Updated